Company Secretary Manasa R resigns effective November 28, 2025
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Manasa R resigned as Company Secretary to pursue a career outside the company. Her departure is effective after close of business on November 28, 2025. She will complete her handover, and the company is seeking a replacement.
This is a senior administrative departure, but the company is arranging a handover and replacement. No financial impact was disclosed.